Generic Name and Formulations:
Poly-ureaurethane 16%; nail solution.
Cipher Pharmaceuticals US LLC
Indications for NUVAIL:
For managing signs/symptoms of nail dystrophy (eg, nail splitting, fragility) for intact or damaged nails.
Apply to affected nail(s) once daily before bedtime. Allow product to dry completely before applying pads or clothing. Clean affected nails with nail polish remover once a week.
Do not apply directly to deep, open, or profusely bleeding wounds.
Product is flammable. Do not allow product to come in contact with floors, countertops, furniture, or other finished surfaces; will stain. Persons sensitized to isocyanate: do not use. Discontinue if redness or irritation occurs.
Ointments, creams, lotions may prevent film from forming correctly and reduce effectiveness if put on before application.
Stinging upon application.
Sol—15mL (w. applicator)
Endocrinology Advisor Articles
- Diabetic Retinopathy Risk Not Increased With GLP-1 Receptor Agonist Use in T2D
- Concurrent Risk Factors and Microvascular Complications in Type 1 Diabetes
- Higher Risk for Meningioma Linked to GH Treatment, Radiotherapy During Childhood
- Early Treatment Intensification and Faster Glycemic Control in T2D
- Comparing Antidiabetic Drug Classes for Risk of Heart Failure
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Hypertension Treatments: ARBs
- Semaglutide vs Liraglutide for Weight Loss in Patients With Obesity
- Liraglutide May Lower Risk for Foot Amputation in Type 2 Diabetes
- Thyroid Hormone Levels, Body Composition, Insulin Resistance in Euthyroid Patients
- Cochrane Data Release and the Case for "Open Science"
- Rates of Incident Type 2 Diabetes in Chronic Kidney Disease
- Characteristics of Acquired Partial Lipodystrophy With Metabolic Abnormalities
- Poor Glycemic Control Associated With Higher Risk for Dementia in Older Adults With T1D
- Shift Seen From EDs to Urgent Care for Low-Acuity, Acute Care